Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Role of Macular Neovascular Membrane Subtype in Pneumatic Displacement of Macular Hemorrhages

NCT07427160 is registered in ClinicalTrials.gov with Marco Mazzola as lead sponsor.

NCT NCT07427160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07427160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Role of Macular Neovascular Membrane Subtype in Pneumatic Displacement of Macular Hemorrhages
Lead sponsor
Marco Mazzola
Phase
Observational
Overall status
Recruiting
Start date
October 15, 2025
Completion date
December 15, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amd - age-related macular degeneration